MIT Biotech startups

Connecting Industry to Startups

STEX Cluster workshop series:

Better innovation in biotech

MIT, 26 February 2015

Trond Undheim, PhDLead, MIT Startup [email protected]

172 MIT Faculty are serial entrepreneurs!

•Prof. Bob Langer, Koch Institute, MIT (26 companies)

•Prof. Alex Pentland, MIT Media Lab (16 companies)

•Noubar Afeyan, MIT Sloan (10 companies)

•Prof. Gregory Stephanopoulos, ChemE (7 companies)

•Prof. Michael Stonebraker, CSAIL (5 companies)

Serial entrepreneurs at MIT

Source: MIT STEX Database (2015).

MIT Startup Exchange

An innovation community run by MIT Industrial Liaison program, with the aim of connecting industry to startups.•Exhibitions•Cluster workshops•Browsing•Opportunity matching•Analytics•STEX Newsletter

Seven startup clusters

327

57

81

64

132

27

64

n=844 Source: MIT STEX Database (2015).

Biotech cluster132 Startups.

8 founded in 2014.

49 at prototype stage.

10 at beta/MVP stage.

25 have a product.

6 have a first customer.

20 are in the growth stage.

Agenda

• 8:45am: Breakfast and registration• 9:05am: Welcome: "MIT's Biotech Startups, Trond Undheim,

Ph.D., Lead, Startup Initiative, MIT Industrial Liaison Program• 9:10am: Introductory remarks: “Connecting industry to research,

innovation, and startups”, Karl Koster, Executive Director,  MIT Industrial Liaison Program

• 9:15am: "Lessons from spinning out biotech firms from university labs", Professor Jeff M Karp, Associate Professor  Harvard Medical School, Co-Director of the Center for Regenerative Therapeutics at the Brigham and Women's Hospital,  MIT  affiliate faculty, Harvard-MIT Division of Health Sciences and Technology. Karp has co-founded the startups Gecko Biomedical and Skintifique.

Agenda

• 9:30am: Keynote: "Better Biotech Innovation by improving the ecosystem”, Tim Charlebois, Ph.D., VP of technology and innovation strategy, Pfizer Biotherapeutics.

• 9:45am: Coffee Break• 9:50am: "The biotech investment horizon", Noubar Afeyan, Senior

Lecturer, MIT Sloan & CEO, Flagship Ventures. • 10:00am: "The pain points or opportunities for biotech innovation

right now", Professor Michael J Cima, David H Koch Professor of Engineering, Koch Institute for Integrative Cancer Research (KIICR), MIT. Cima is the co-founder of T2 Biosystems, TARIS Biomedical Inc., and Microchips Biotech.

• 10:15am: "Fostering Massachusetts' life science ecosystem", Dr. Susan Windham-Bannister, President and CEO of the Massachusetts Life Sciences Center (MLSC). 

Panel discussion

10:30am: Panel discussion: “Better Innovation in Biotech”•What are important trends in biotech startups from MIT (and elsewhere)? •What does the new biotech innovation ecosystem look like (infrastructure, interoperability, technology, use cases, stakeholders, success stories)? •What are corporate priorities in biotech? •What is the smart money focused on?

Panelists

• Tim Charlebois, Ph.D ., VP of technology and innovation strategy, Pfizer Biotherapeutics.

• Professor Michael J Cima, David H Koch Professor of Engineering, Koch Institute for Integrative Cancer Research (KIICR), MIT

• Dr. Susan Windham-Bannister, President and CEO of the Massachusetts Life Sciences Center (MLSC)

• MIT startup execs (Patrick Anquetil, CEO Portal Instruments, Christopher Pirie , Co-Founder, Manus Biosynthesis, Armon Sharei, PhD, CEO, SQZ Biotechnologies, Ben Warner, Founder, XRpro Inc.)

• Noubar Afeyan, Senior Lecturer, MIT Sloan & CEO, Flagship Ventures

The panel debate will be moderated by Sheryl Greenberg, Senior Industrial Liaison Officer, MIT ILP

Connecting Industry to Startups